Biotech

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Nexvet Biopharma Plc. (NASDAQ:NVET) reported that Farallon Capital has picked up 1,046,345 of common stock as of 2017-04-19. The acquisition brings the aggregate amount owned by Farallon Capital to a total of 1,046,345 representing a...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Ocera Therapeutics Inc. (NASDAQ:OCRX) reported that Perceptive Advisors has picked up 2,150,000 of common stock as of 2017-04-17. The acquisition brings the aggregate amount owned by Perceptive Advisors to a total of 2,150,000 representing approximately...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) reported that Ronin Capital, Llc. has picked up 95,059 of common stock as of 2017-04-17. The acquisition brings the aggregate amount owned by Ronin Capital, Llc. to a total of 95,059 representing...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Biolase Inc. (NASDAQ:BIOL) reported that Schuler Jack W has picked up 20,728,060 of common stock as of 2017-04-17. The acquisition brings the aggregate amount owned by Schuler Jack W to a total of 20,728,060 representing...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Angiodynamics Inc. (NASDAQ:ANGO) reported that Avista Capital Partners Gp, Llc. has picked up 2,333,008 of common stock as of 2017-04-14. The acquisition brings the aggregate amount owned by Avista Capital Partners Gp, Llc. to a...